← Back to Search

Virus Therapy

Long-Term Follow-Up of EBT-101 for HIV

Phase 1
Waitlist Available
Research Sponsored by Excision BioTherapeutics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 15 years
Awards & highlights

Study Summary

This trial is for people who have taken EBT-101 before and are willing to be monitored for long-term effects.

Who is the study for?
This trial is for adults with HIV who have previously received the investigational treatment EBT-101 in an earlier study. They must have signed a consent form agreeing to participate and be monitored over time.Check my eligibility
What is being tested?
The focus of this study is on long-term follow-up of patients who were treated with EBT-101, which is a new intervention for HIV. The goal is to observe the extended effects and outcomes after initial treatment.See study design
What are the potential side effects?
Since this is a follow-up study, specific side effects are not listed here. However, it will monitor any long-term side effects from the previous use of EBT-101 in participants.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~15 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 15 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Long-term safety of EBT-101

Trial Design

1Treatment groups
Experimental Treatment
Group I: Long Term Follow UpExperimental Treatment1 Intervention
Participants who received EBT-101 in a parent study will undergo long term follow up

Find a Location

Who is running the clinical trial?

Excision BioTherapeuticsLead Sponsor
1 Previous Clinical Trials
9 Total Patients Enrolled
William Kennedy, MDStudy DirectorExcision BioTherapeutics
1 Previous Clinical Trials
9 Total Patients Enrolled
Study DirectorStudy DirectorExcision BioTherapeutics
1,207 Previous Clinical Trials
489,671 Total Patients Enrolled

Media Library

EBT-101 (Virus Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT05143307 — Phase 1
HIV Research Study Groups: Long Term Follow Up
HIV Clinical Trial 2023: EBT-101 Highlights & Side Effects. Trial Name: NCT05143307 — Phase 1
EBT-101 (Virus Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05143307 — Phase 1
HIV Patient Testimony for trial: Trial Name: NCT05143307 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are applications now open for this medical research?

"Correct. Clinicaltrials.gov records indicate that this clinical trial, initially posted on March 1st 2023 and last updated October 17th 2022 is not actively seeking patients at the present moment. However, there are 107 other medical studies currently recruiting participants."

Answered by AI

How extensive is the coverage of this research trial in Canadian hospitals?

"Seven clinical trial sites are facilitating the current medical study, such as Clinical Trial Site in Orlando, Cooper Health in Saint Louis and Washington University in Camden. Additionally, there are four other facilities delivering the same service."

Answered by AI

What potential hazards are associated with the ingestion of EBT-101?

"The safety profile of EBT-101 has been assessed by our team at Power, who rated it with a score of 1 due to the limited research conducted on its efficacy and potential risks."

Answered by AI

Who else is applying?

What state do they live in?
California
Texas
How old are they?
18 - 65
What site did they apply to?
Washington University
Clinical Trial Site
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I want to be part of a cure and to possible live with out HIV.
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
Long-Term Follow-Up Study of HIV-1 Infected Adults Who Received EBT-101
2023. "Long-Term Follow-Up Study of HIV-1 Infected Adults Who Received EBT-101". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05143307.
~6 spots leftby Jan 2037
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top